Tirzepatide/B12 Compound

Category: Compound Blend

A compounded formulation pairing Tirzepatide (a dual GIP/GLP-1 receptor agonist) with Methylcobalamin (Vitamin B12). The B12 component is added to help offset fatigue, anemia risk, and potential neurological side effects associated with extended GLP-1 use and reduced food intake. Commonly prescribed by weight loss clinics.

Half-Life: 120 hours

Common Dosage: 2.5mg + B12

Benefits

  • Dual GIP/GLP-1 weight loss mechanism (superior to GLP-1 alone)
  • B12 supplementation mitigates fatigue and energy dip
  • May reduce risk of B12 deficiency from reduced dietary intake
  • Improved mood and energy levels alongside weight loss
  • Convenient single injection contains both compounds

Side Effects

  • Nausea and vomiting (Tirzepatide component)
  • Diarrhea or constipation
  • Injection site reactions
  • Decreased appetite
  • Fatigue (reduced by B12)
  • Mild B12-related flushing (rare)